8-K Amylyx Pharmaceuticals, Inc. 2026-09-08: filing_form_type
| Value | {"value": "8-K"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Amylyx Pharmaceuticals, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1658551/000119312526385331/0001193125-26-385331-in
Retrieved: 2026-09-08T23:04:37.176163+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/d54dc852-1395-4152-b44c-7dacbb4bd01c
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1658551/000119312526385331/0001193125-26-385331-in
Retrieved: 2026-09-08T23:04:37.176163+02:00
Raw response sha256:
3d157452fb5f40945b50314d538cbe11…Cite as: FACTANKER, https://factanker.com/fact/d54dc852-1395-4152-b44c-7dacbb4bd01c
History
- no predecessors — first report